{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:52:38Z","timestamp":1770223958949,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["surgjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.surg.2018.06.025","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T09:32:41Z","timestamp":1533547961000},"page":"1014-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma"],"prefix":"10.1016","volume":"164","author":[{"given":"Hidetoshi","family":"Gon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motofumi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisoka","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tsugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Awazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirochika","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippei","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2018.06.025_bib0001","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.surg.2018.06.025_bib0002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials","volume":"29","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.surg.2018.06.025_bib0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amjsurg.2006.06.051","article-title":"Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma","volume":"194","author":"Ibrahim","year":"2007","journal-title":"Am J Surg"},{"key":"10.1016\/j.surg.2018.06.025_bib0004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.surg.2018.06.025_bib0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhep.2000.9603","article-title":"Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival","volume":"32","author":"Villa","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.surg.2018.06.025_bib0006","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.surg.2018.06.025_bib0007","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial","volume":"57","author":"Bruix","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.surg.2018.06.025_bib0008","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ejca.2011.12.006","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial","volume":"48","author":"Cheng","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surg.2018.06.025_bib0009","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","article-title":"A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations?: An observational study of the HCC East-West study group","volume":"257","author":"Torzilli","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2018.06.025_bib0010","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ejca.2008.02.018","article-title":"The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma\u2014Survival analysis of 3892 patients","volume":"44","author":"Wang","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surg.2018.06.025_bib0011","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00535-007-2134-9","article-title":"Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: Prognostic features, treatment outcome, and survival","volume":"43","author":"Changchien","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.surg.2018.06.025_bib0012","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1072-7515(00)00740-7","article-title":"Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis","volume":"191","author":"Ohkubo","year":"2000","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2018.06.025_bib0013","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jamcollsurg.2005.11.012","article-title":"Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein","volume":"202","author":"Ikai","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2018.06.025_bib0014","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.surg.2004.12.012","article-title":"Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: Results of a multicenter study","volume":"137","author":"Pawlik","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2018.06.025_bib0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000658-200103000-00012","article-title":"Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus","volume":"233","author":"Minagawa","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2018.06.025_bib0016","doi-asserted-by":"crossref","unstructured":"Inoue Y, Hasegawa K, Ishizawa T, Aoki T, Sano K, Beck Y, et al. Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? Surgery 2009;145:9-19.","DOI":"10.1016\/j.surg.2008.09.005"},{"key":"10.1016\/j.surg.2018.06.025_bib0017","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s00595-017-1507-9","article-title":"New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch","volume":"47","author":"Fukumoto","year":"2017","journal-title":"Surg Today"},{"key":"10.1016\/j.surg.2018.06.025_bib0018","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2018.06.025_bib0019","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000327577","article-title":"Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version","volume":"29","author":"Kudo","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.surg.2018.06.025_bib0020","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.surg.2018.06.025_bib0021","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.surg.2018.06.025_bib0022","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C","volume":"20","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.surg.2018.06.025_bib0023","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jhep.2016.05.044","article-title":"Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion","volume":"65","author":"Kokudo","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.surg.2018.06.025_bib0024","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1139\/y96-029","article-title":"The 1995 Ciba-Geigy Award Lecture. Intrinsic regulation of hepatic blood flow","volume":"74","author":"Lautt","year":"1996","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.surg.2018.06.025_bib0025","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3748\/wjg.v10.i6.819","article-title":"Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells","volume":"10","author":"Li","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2018.06.025_bib0026","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.canlet.2006.09.004","article-title":"Alpha-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand","volume":"249","author":"Li","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.surg.2018.06.025_bib0027","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.27362","article-title":"Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study","volume":"60","author":"Loomba","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.surg.2018.06.025_bib0028","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","article-title":"Performance of transient elastography for the staging of liver fibrosis: A meta-analysis","volume":"134","author":"Friedrich-Rust","year":"2008","journal-title":"Gastroenterology"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606018303696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606018303696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T15:07:02Z","timestamp":1539356822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606018303696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0039606018303696"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2018.06.025","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2018.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}